Keros to Exclusively Prioritize the Clinical Advancement of KER-065
Go back to Keros to Exclusively Prioritize the Clinical Advancement of KER-065| (NASDAQ: KROS) | Delayed: 10.83 -0.2 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.03 | 52 Week High | $ | |||
| Open | $11.12 | 52 Week Low | $ | |||
| Day High | $11.12 | P/E | N/A | |||
| Day Low | $10.72 | EPS | $ | |||
| Volume | 36,235 | |||||
